Kirin (KNBWY) Stock Chart & Stock Price History → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free KNBWY Stock Alerts $14.36 +0.12 (+0.84%) (As of 04:27 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartEarningsFinancialsInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsInsider TradesSEC FilingsShort Interest Kirin Stock Price Performance5 Day Performance+2.43%1 Month Performance+2.21%3 Month Performance+2.28%6 Month Performance+2.64%Year-To-Date Performance-1.71%1 Year Performance-9.00% Receive KNBWY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Kirin and its competitors with MarketBeat's FREE daily newsletter Email Address Ad AltimetrySecret Bull Market Starts in This Unusual Sector"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch. Click for my No. 1 investment, all free of charge, click here. KNBWY Stock Chart for Friday, April, 19, 2024 KNBWY Chart by TradingView Kirin Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$14.24$14.24$14.27$14.2259,536 shs$0.0004/17/2024$14.21$14.24+0.21%$14.24$14.17110,554 shs$0.0004/16/2024$14.30$14.21-0.63%$14.30$14.15113,046 shs$0.0004/15/2024$14.02$14.30+2.00%$14.33$14.0560,260 shs$0.0004/12/2024$14.01$14.16+1.07%$14.30$14.0024,634 shs$0.0004/11/2024$13.98$14.01+0.21%$14.26$13.9456,518 shs$0.00 Get the Latest News and Ratings for KNBWY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kirin and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$14.17$13.98-1.34%$14.02$13.7030,389 shs$0.0004/09/2024$14.17$14.17$14.61$14.1462,504 shs$0.0004/08/2024$13.96$14.17+1.50%$14.20$13.9162,504 shs$0.0004/05/2024$13.81$13.96+1.09%$14.00$13.9261,493 shs$11.64 billion04/04/2024$13.81$13.81$13.94$13.7070,814 shs$0.0004/03/2024$13.76$13.81+0.36%$14.25$13.6970,738 shs$0.0004/02/2024$13.79$13.76-0.22%$13.76$13.4096,789 shs$0.0004/01/2024$13.89$13.79-0.73%$13.82$13.65155,951 shs$0.0003/29/2024$13.89$13.89$14.40$13.8034,122 shs$0.0003/28/2024$13.88$13.89+0.08%$14.40$13.8034,122 shs$0.0003/27/2024$13.83$13.88+0.36%$14.31$13.8659,006 shs$0.0003/26/2024$13.77$13.83+0.44%$13.87$13.75131,279 shs$0.0003/25/2024$13.94$13.77-1.18%$13.82$13.77177,233 shs$11.48 billion03/22/2024$13.92$13.94+0.11%$13.97$13.9157,579 shs$0.0003/21/2024$14.01$13.92-0.66%$13.98$13.5529,850 shs$0.0003/20/2024$14.05$14.01-0.27%$14.02$13.8730,161 shs$11.68 billion03/19/2024$14.00$14.05+0.36%$14.05$13.9161,053 shs$0.0003/18/2024$13.99$14.00+0.07%$14.08$13.8740,078 shs$0.0003/15/2024$13.89$13.99+0.72%$14.02$13.9466,228 shs$11.66 billion03/14/2024$13.80$13.89+0.65%$14.00$13.8257,912 shs$0.0003/13/2024$13.85$13.80-0.36%$13.87$13.4225,094 shs$0.0003/12/2024$13.84$13.85+0.07%$13.89$13.8074,700 shs$0.0003/11/2024$13.84$13.84$13.84$13.4650,582 shs$11.54 billion03/08/2024$13.89$13.84-0.36%$13.93$13.5661,621 shs$0.0003/07/2024$13.77$13.89+0.87%$13.92$13.60100,139 shs$0.0003/06/2024$13.58$13.77+1.40%$13.85$13.4286,480 shs$11.48 billion03/05/2024$13.58$13.58$13.61$13.4964,880 shs$0.0003/04/2024$13.84$13.58-1.88%$13.81$13.58221,795 shs$0.0003/01/2024$13.81$13.84+0.22%$13.88$13.8161,889 shs$0.0002/29/2024$13.85$13.81-0.29%$13.92$13.8174,463 shs$0.0002/28/2024$13.96$13.85-0.79%$13.92$13.8120,839 shs$0.0002/27/2024$14.26$13.96-2.10%$14.20$13.9131,498 shs$0.0002/26/2024$14.23$14.26+0.21%$14.26$14.2021,257 shs$0.0002/23/2024$14.35$14.23-0.84%$14.28$13.8527,809 shs$0.00Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>>02/22/2024$14.30$14.35+0.35%$14.83$14.2438,886 shs$0.0002/21/2024$14.30$14.30$14.30$14.2437,538 shs$11.92 billion02/20/2024$14.10$14.30+1.42%$14.32$14.1028,763 shs$0.0002/19/2024$14.10$14.10$14.12$14.0327,300 shs$0.0002/16/2024$14.02$14.10+0.57%$14.12$14.0327,364 shs$11.75 billion02/15/2024$14.40$14.02-2.64%$14.40$13.9736,363 shs$0.0002/14/2024$14.39$14.40+0.07%$14.65$14.4053,324 shs$0.0002/13/2024$14.45$14.39-0.38%$14.56$14.3920,878 shs$0.0002/12/2024$14.42$14.45+0.17%$14.48$14.3817,798 shs$0.0002/09/2024$14.38$14.42+0.28%$14.43$14.3733,030 shs$0.0002/08/2024$14.31$14.38+0.49%$14.40$14.3235,498 shs$0.0002/07/2024$14.40$14.31-0.62%$14.33$14.2691,843 shs$0.0002/06/2024$14.34$14.40+0.42%$14.49$14.3540,246 shs$12.00 billion02/05/2024$14.35$14.34-0.07%$14.54$14.3033,497 shs$0.0002/02/2024$14.42$14.35-0.49%$14.35$14.2121,654 shs$0.0002/01/2024$14.29$14.42+0.91%$14.43$14.2518,829 shs$0.0001/31/2024$14.21$14.29+0.56%$14.45$14.2935,204 shs$0.0001/30/2024$14.25$14.21-0.28%$14.23$14.1831,068 shs$0.0001/29/2024$14.02$14.25+1.64%$14.26$14.0656,289 shs$0.0001/26/2024$14.06$14.02-0.25%$14.10$14.0224,017 shs$0.0001/25/2024$14.08$14.06-0.18%$14.15$14.0336,367 shs$0.0001/24/2024$14.23$14.08-1.05%$14.15$14.0833,461 shs$0.0001/23/2024$14.17$14.23+0.42%$14.26$14.2235,999 shs$0.0001/22/2024$14.04$14.17+0.93%$14.25$14.11172,685 shs$11.81 billion01/19/2024$14.11$14.04-0.50%$14.04$14.0074,498 shs$0.0001/18/2024$14.20$14.11-0.63%$14.18$14.11108,178 shs$0.00 Related Companies: Heineken Stock Chart Mendocino Brewing Stock Chart Tsingtao Brewery Stock Chart American Community Newspapers Stock Chart American Premium Mining Stock Chart Axia International Group Stock Chart BIQI International Stock Chart Blue Gem Enterprise Stock Chart CCA Industries Stock Chart Centennial Specialty Foods Stock Chart Receive KNBWY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kirin and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:KNBWY) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIHe Is Giving Away BitcoinCrypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow Biden has already won 2024Porter & CompanyUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kirin Holdings Company, Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.